REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 16th, 2017 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 15, 2017 by and among Argos Therapeutics, Inc., a Delaware corporation (the “Company”), and Pharmstandard International S.A. (“PHS”). Capitalized terms used herein have the respective meanings ascribed thereto in that certain Note Purchase Agreement dated as of the date hereof by and among the Company and PHS (the “Purchase Agreement”) unless otherwise defined herein.
NOTE PURCHASE AGREEMENTNote Purchase Agreement • June 16th, 2017 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
This NOTE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 15, 2017 by and among Argos Therapeutics, Inc., a Delaware corporation (the “Company”) and Pharmstandard International S.A. (the “Investor”).
